Results 191 to 200 of about 1,274,222 (313)

Prediction of pre- and postfusion conformations of class I fusion proteins with AlphaFold2. [PDF]

PLoS One
Gülesen S, Most V, Schoeder CT, Meiler J.   +3 more
europepmc   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

Molecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, Mara S Serafini, Qiang Zhang, Youbin Zhang, Lorenzo Gerratana, Andrew A. Davis, Huiping Liu, William J Gradishar, Carolina Reduzzi, Massimo Cristofanilli, Evi Lianidou   +12 more
wiley   +1 more source

Ten quick tips for classifying unknown bacteriophage. [PDF]

PLoS Comput Biol
Bastiaanssen FTS, Hill C, Shkoporov AN.
europepmc   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

The Biology of Huntingtin.

Neuron, 2016
F. Saudou, S. Humbert
semanticscholar   +1 more source

Positioning HIV SMRTcap within the HIV reservoir toolbox. [PDF]

PLoS Pathog
Loddo A, Delobel P, Vellas C.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Gaps as characters in sequence-based phylogenetic analyses.

Systematic Biology, 2000
Mark P. Simmons, H. Ochoterena
semanticscholar   +1 more source

Beyond the canonical: The role of post-transcriptional regulation in drug-target interaction prediction. [PDF]

PLoS Comput Biol
Ansari MI, Ahmed KT, Wang DD, Medvedev K, Zhang W.   +4 more
europepmc   +1 more source

Global analysis of SNPs, proteins and protein-protein interactions: approaches for the prioritisation of candidate disease genes.

, 2009
PhDUnderstanding the etiology of complex disease remains a challenge in biology. In recent years there has been an explosion in biological data, this study investigates machine learning and network analysis methods as tools to aid candidate disease ...
Dobson, Richard James Butler
core